Dopamine D3 receptor ligands for the treatment of tobacco dependence (Q36677397)

15 August 2017

1 reference

title

Dopamine D3 receptor ligands for the treatment of tobacco dependence (English)

1 reference

15 August 2017

3

Pierre Sokoloff

1 reference

15 August 2017

Bernard Le Foll

1

1 reference

PubMed ID

17155853

15 August 2017

Steven R Goldberg

series ordinal

2

1 reference

PubMed ID

17155853

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Expert Opinion on Investigational Drugs

15 August 2017

1 reference

15 August 2017

16

1 reference

15 August 2017

45-57

1 reference

15 August 2017

1

1 reference

Nicotine as a reinforcer in human subjects and laboratory animals.

15 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The neurobiology of tobacco addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Smoking cessation guidelines for health professionals: an update. Health Education Authority

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Brain dopamine and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Dopamine, learning and motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Opiate antagonists reduce cocaine but not nicotine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Molecular cloning and expression of the gene for a human D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Human dopamine D1 receptor encoded by an intronless gene on chromosome 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Cloning and expression of human and rat D1 dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Disruption of nicotine conditioning by dopamine D(3) receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Neuroadaptation. Incubation of cocaine craving after withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The dopamine D3 receptor and drug dependence: effects on reward or beyond?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Animal models of drug craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Second-order schedules of drug self-administration in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Evidence for addiction-like behavior in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Drug seeking becomes compulsive after prolonged cocaine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Nicotine maintains robust self-administration in rats on a limited-access schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

A description of the nicotine stimulus and tests of its generalization to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Reinstatement and spontaneous recovery of nicotine seeking in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Nicotine as a typical drug of abuse in experimental animals and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Nicotine self-administration in animals and humans: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Nicotine self-administration in rats on a progressive ratio schedule of reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The GABA B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Importance of nonpharmacological factors in nicotine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Reinstatement of cocaine-reinforced responding in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Nicotine induces conditioned place preferences over a large range of doses in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The reinstatement model of drug relapse: history, methodology and major findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The validity of the reinstatement model of craving and relapse to drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Cytisine for smoking cessation: a literature review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Effect of nicotine on the tobacco withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The effect of bupropion on nicotine craving and withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

How does bupropion work as a smoking cessation aid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Nicotine and bupropion share a similar discriminative stimulus effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Investigating the actions of bupropion on dependence-related effects of nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Effect of bupropion on nicotine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Drug discrimination in neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Behavioural despair in rats: A new model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

CB1 receptor antagonists for the treatment of nicotine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

Effect of Nicotine Replacement on the Cigarette Withdrawal Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.45

21 January 2018

Identifiers

DOI

10.1517/13543784.16.1.45

1 reference

15 August 2017

1 reference

PubMed ID

17155853